Compare ADSK & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADSK | TEVA |
|---|---|---|
| Founded | 1982 | 1901 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.8B | 40.5B |
| IPO Year | 1994 | 1996 |
| Metric | ADSK | TEVA |
|---|---|---|
| Price | $254.10 | $37.57 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 26 | 8 |
| Target Price | ★ $335.04 | $38.63 |
| AVG Volume (30 Days) | 1.8M | ★ 5.6M |
| Earning Date | 05-21-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 2.15 | ★ 183.45 |
| EPS | ★ 2.32 | N/A |
| Revenue | ★ $7,206,000,000.00 | N/A |
| Revenue This Year | $15.35 | N/A |
| Revenue Next Year | $10.36 | $2.97 |
| P/E Ratio | $108.22 | ★ N/A |
| Revenue Growth | ★ 17.53 | N/A |
| 52 Week Low | $185.50 | $17.82 |
| 52 Week High | $329.09 | $37.83 |
| Indicator | ADSK | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 59.55 | 64.02 |
| Support Level | $227.17 | $30.42 |
| Resistance Level | $250.27 | $37.17 |
| Average True Range (ATR) | 8.04 | 0.82 |
| MACD | -0.58 | 0.13 |
| Stochastic Oscillator | 65.56 | 78.81 |
Founded in 1982, Autodesk is a multinational software company best known for pioneering computer-aided design, or CAD, with its AutoCAD product. Nowadays, Autodesk provides design software for a variety of verticals, including architecture & construction, manufacturing, and media & entertainment. Autodesk products have been used in some of the world's most iconic landmarks, like Burj Khalifa, and well-known movie titles like Avatar.
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.